Mouse Anti-CREB5 Recombinant Antibody (CBFYC-2198) (V2LY-1206-LY1118)

Wang, S., Qiu, J., Liu, L., Su, C., Qi, L., Huang, C., ... & Liao, W. (2020). CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET. Journal of Experimental & Clinical Cancer Research, 39(1), 1-11.

Zhang, X., Xu, Y., Yamaguchi, K., Hu, J., Zhang, L., Wang, J., ... & Chen, W. (2020). Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis. Cancer Cell International, 20(1), 1-11.

Zhang, M., Li, Y., Wang, H., Yu, W., Lin, S., & Guo, J. (2019). LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5. Cancer biology & therapy, 20(4), 524-536.

Wu, J., Wang, S. T., Zhang, Z. J., Zhou, Q., & Peng, B. G. (2018). CREB5 promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology, 11(10), 4908.

Yu, M., Du, G., Xu, Q., Huang, Z., Huang, X., Qin, Y., ... & Lu, C. (2018). Integrated analysis of DNA methylome and transcriptome identified CREB5 as a novel risk gene contributing to recurrent pregnancy loss. EBioMedicine, 35, 334-344.

He, S., Deng, Y., Liao, Y., Li, X., Liu, J., & Yao, S. (2017). CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer. Oncology Letters, 14(6), 8156-8161.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-CREB5 Recombinant Antibody (CBFYC-2199)

Mouse Anti-CREB5 Recombinant Antibody (8A5)

Isotype control